SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
719They can say they were misinterpreted - what they meant was that it was going Utom pope-10/3/2005
718Have to think that Malloy will have to reassess GS's UP rating on VRTX at soquidditch-10/3/2005
717New Data Suggest Vertex's Oral Hepatitis C Virus Protease Inhibitor VX-950 Mcaly-10/3/2005
716=DJ Vertex Up: Credit Suisse Ups Sales View For Hep C Pdt 30 Sep 13:05 By LJM-9/30/2005
715Interesting difference of opinion over the past year, but the last two have beencaly-9/29/2005
714Just to keep it going here, Boger's comments a week ago or so on 950 and P38quidditch-9/27/2005
713Vertex to refinance more than $40M in debt Friday September 9, 3:06 pm ET Vertmopgcw-9/12/2005
712Market Pulse: Vertex Pharma upped at J.P. Morgan; hepatitis C drug cited Fridaycaly-8/19/2005
711Vertex Pharma Starts Phase II Study For Arthritis Drug DOW JONES NEWSWIRES Junemopgcw-6/10/2005
710Vertex Pharmaceuticals Announces Pricing of Common Stock Offering 7:03 PM ET Junmopgcw-6/8/2005
709GS: VRTX (U/N): VX950 strong Phase Ib data detailed at DDW 52-Week Range US$13-mopgcw-6/8/2005
708From Forbes: forbes.com Stock Of The Week Vertex Stock Goes Vertical John Docaly-5/18/2005
707Vertex Pharmaceuticals Reports that VX-950, an Investigational Oral Hepatitis C Doc Bones-5/10/2005
70621-Apr-05 Needham & Co Initiated Buy 14-Apr-05 Adams Harkness Initiated Bcaly-4/21/2005
705Up after hours on this news... Federal Court Orders Dismissal of Shareholder Lacaly-2/23/2005
704The following release was issued today: Vertex Pharmaceuticals Licenses VX-944Casaubon-2/15/2005
703GS: VRTX (U/N): Q4 update; lower 05 loss est.; focus 2005 data 52-Week Range USmopgcw-2/14/2005
702I guess the presentation was well-received. Still need to listen to the webcastcaly-2/4/2005
701Forbes article on VX-950. Magic Bullet for Hepatitis C forbes.comcaly-1/24/2005
700"Aurora Kinase Inhibitors as Anticancer Agents" nature.com Nature Retuck-1/10/2005
699>>CAMBRIDGE, Mass., Jan. 10 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticatuck-1/10/2005
698Vertex and Merck Announce First Clinical Study for Aurora Kinase Inhibitor, VX-6mopgcw-1/7/2005
697GS: VRTX(U/N): Management update, pipeline early but progressing 52-Week Range mopgcw-11/30/2004
696Does anybody have an explanation for the wide daily swings of the share price? FAlfred W. Post-11/11/2004
695Does anybody have an explanation for the wide daily swings of the share price? FAlfred W. Post-11/11/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News